MUC1 Vaccine for Triple-negative Breast Cancer
Clinical trial NCT00986609 · COMPLETED
Trial details
- NCT number
- NCT00986609
- Sponsor
- Joseph Baar, MD, PhD
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-19
- Primary completion
- 2013-08-29
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.